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Summary
The structural plasticity of neurites in the central nervous system (CNS) diminishes dramatically 
after initial development, but the peripheral nervous system (PNS) retains substantial plasticity 
into adulthood. Nevertheless, functional reinnervation by injured peripheral sensory neurons is 
often incomplete [1–6]. To investigate the developmental control of skin reinnervation we imaged 
the regeneration of trigeminal sensory axon terminals in live zebrafish larvae following laser 
axotomy. When axons were injured during early stages of outgrowth, regenerating and uninjured 
axons grew into denervated skin and competed with one another for territory. At later stages, after 
the establishment of peripheral arbor territories, the ability of uninjured neighbors to sprout 
diminished severely, and although injured axons reinitiated growth, they were repelled by 
denervated skin. Regenerating axons were repelled specifically by their former territories, 
suggesting that local inhibitory factors persist in these regions. Antagonizing the function of 
several members of the Nogo Receptor (NgR)/RhoA pathway improved the capacity of injured 
axons to grow into denervated skin. Thus, as in the CNS, impediments to reinnervation in the PNS 
arise after initial establishment of axon arbor structure.
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Results
Regenerating sensory axons avoid their former territories in the skin at later 
developmental stages
The peripheral axons of trigeminal sensory neurons terminate in elaborate arbors within the 
skin of the head to mediate somatosensation. Although it is well known that the primary 
axons of peripheral sensory neurons possess substantial regenerative capacity [reviewed in 
1], few studies have examined the regenerative potential of unmyelinated axon terminals in 
the skin. We used zebrafish trigeminal neurons as a model to investigate the developmental 
regulation of cutaneous axon terminal plasticity and whether deficits in skin reinnervation 
may contribute to incomplete recovery following injury.
The skin of larval zebrafish consists of two epithelial layers, between which trigeminal axon 
terminals reside. These axons repel one another as they arborize to partition epidermal 
territory, leading to complete, minimally redundant innervation of the head by 36 hours post-
fertilization (hpf) [7]. To study the developmental control of skin reinnervation after injury, 
we severed the peripheral arbors of zebrafish trigeminal neurons expressing green 
fluorescent protein (GFP) with a femtosecond laser (Figure S1) [8], imaged their 
regeneration in live embryos for 12 hours, and traced their structure to quantify the success 
of target reinnervation (Figure 1 and supplemental movies). To specifically study axon 
regeneration within the skin, all axotomies were directed to second or third order axon 
branches, which are situated between the two skin layers.
Axon regeneration was analyzed at three stages: 30 hpf, when trigeminal peripheral axons 
are still actively arborizing; 54 hpf, ~18 hours after arborization is complete; and 78 hpf. In 
all cases, the distal portions of severed axons degenerated and were cleared within three 
hours, leaving a denervated region of skin. Regenerating axons always partially reinnervated 
their former territories after axotomy at 30 hpf, but their capacity for reinnervation was 
significantly diminished after axotomy at 54 hpf, and virtually nonexistent at 78 hpf. The 
portion of former territory reinnervated decreased from 47.5 ± 7.9 % at 30 hpf to 0.3 
± 0.2 % at 78 hpf (p<0.0001); the percent of new growth that entered the denervated region 
decreased from 58 ± 6.3 % at 30 hpf to 12.4 ± 8 % at 78 hpf (p=0.0002; Figure 2; Table S1). 
Most axons severed at 78 hpf initiated new growth, but actively avoided their former 
territories (Figure 2G–I). Avoidance was manifested as several distinct axon behaviors 
(Figure S2), including stalling, skirting the edge of the territory, or turning sharply, none of 
which were observed after axotomy at 30 hpf. Strikingly, although one-third (6/18) of axons 
severed at 78 hpf re-entered their former territory, reinnervation was always transient: axons 
that entered the denervated territory either retracted (2/6; Figure S2F–J), degenerated locally 
(2/6), or the parent neuron died (2/6; Figure S2K–O). Neither phagocytic blood cells nor 
peripheral myelin were responsible for inhibition, since avoidance was still observed in 
cloche mutant fish, which lack all blood cells [9], and in fish treated with the drug AG1478, 
which lack peripheral myelination (Figure S3; Table S2) [10]. Axon avoidance of former 
territory was a persistent effect, as axons imaged for five days after 78 hpf axotomy never 
reinnervated their former territory (n=7; Figure S4).
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Developmental regulation of axon plasticity and tiling
During early larval zebrafish development, trigeminal axons repel one another to partition 
epidermal territory [7]. When arbors are removed early in development, neighboring axons 
expand to fill denervated territory. This strategy for partitioning arbor territories, known as 
“tiling”, is often employed when multiple neurons of the same type innervate a two 
dimensional target. Although the arbors of some tiled neurons retain plasticity into 
adulthood [e.g. 11, 12], allowing them to compensate for the loss of neighbors and create 
new innervation patterns after injury, many populations of tiled neurites cannot reorganize 
after developmental critical periods [e.g. 13, 14, 15].
To characterize the territory partitioning strategy of trigeminal sensory terminals after injury 
at different developmental stages, we first investigated the ability of uninjured axons to 
sprout into newly denervated territory. To accomplish this, we laser ablated every cell within 
a trigeminal ganglion (Figure S1E,F) and calculated the axon growth rate from the uninjured 
contralateral ganglion into newly denervated territory. When a trigeminal ganglion was 
ablated at 30 hpf, uninjured axons from the contralateral ganglion reinnervated most of the 
denervated skin within 12 hours (Figure 3A). Following ablation at 78 hpf, growth into 
denervated territory was markedly reduced and very little branching occurred (Figure 3B–C; 
Table S3; μm/hr/tip: 30 hpf 5.7 ± 0.3, 78 hpf 0.5 ± 0.2; p=0.0071). Thus, there is a critical 
period after which the growth of uninjured axons into denervated territory diminished 
severely.
To test directly the hypothesis that uninjured and regenerating axons compete for denervated 
territory after injury at 30 hpf, we transplanted wildtype cells into neurogenin-1 morphants, 
which lack somatosensory neurons, generating zebrafish with a single trigeminal neuron [7]. 
Strikingly, isolated axons severed at 30 hpf reinnervated virtually all (98.1 ± 1.9 %) of their 
former territories and grew beyond them (Figure 3E,H). In contrast, control axons (wildtype 
cells transplanted into wildtype embryos) only partially (27.3 ± 16.1 %; p= 0.008) 
reinnervated their former territories (Figure 3D,H). Thus, incomplete reinnervation of former 
territory at 30 hpf was not due to a non-permissive environment in the denervated region, but 
rather to competition with uninjured neighboring axons (Figure 3I).
The peripheral axons of isolated neurons grow until they fill the entire head, long past 78 hpf 
[7]. However, following axotomy of isolated arbors at 78 hpf, regenerating axons avoided 
their former territories, with no significant change in the percent area reinnervated compared 
to wildtype control transplants (1.04 ± 0.8 % vs. 5.4 ± 4.3 %; p=0.3387; Figure 3F–H). 
These results demonstrate that the denervated region actively repels regenerating axons at 
older developmental stages, and that neither diminished growth rate nor competition from 
uninjured neighboring axons explains the lack of reinnervation (Figure 3I). Thus, contrary to 
expectation, the PNS is not always a permissive environment for regeneration: At later larval 
stages local factors persistently marking former territories repel regenerating axons.
A Nogo Receptor/RhoA pathway is required for inhibition of skin reinnervation
We hypothesized that axons in the CNS and PNS use similar molecular mechanisms to 
respond to inhibitors in their respective environments. In the CNS, myelin-associated 
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inhibitors activate a receptor complex that includes NgR and LINGO-1 to block axon 
regeneration [16–19]. This complex activates an intracellular signaling cascade that involves 
the small GTPase RhoA, Rho kinase, and Collapsin Response Mediator Protein 2 (CRMP-2) 
to cause growth cone collapse [20, 21]. Zebrafish trigeminal neurons express homologs of 
Nogo Receptor (ZF NgR), LINGO-1 (LINGO-1a), and CRMP-2 during larval stages [22–
26].
To test whether the NgR pathway functions in peripheral sensory axon regeneration, we 
misexpressed dominant negative (DN) versions of ZF NgR, LINGO-1a and CRMP-2, as 
well as human RhoA, in trigeminal neurons, along with GFP [27–30]. Expression of all the 
DN transgenes increased the fraction of regenerating axons that entered their former 
territories at 78 hpf, compared to control axons co-expressing GFP and RFP, or axons 
expressing full length genes (Figure 4; Figure S5; Table S2). As an additional control, we 
mutated a conserved amino acid in the DN NgR transgene (D163A) required for NgR 
binding to LINGO-1 and all known NgR ligands [31]. Axons expressing DN NgR D163A 
avoided their former territory, similar to controls (Figure 4B,D; Figure S5D,K; Table S2) and 
significantly different from those expressing DN NgR. Blocking Rho kinase (ROCK) with 
the specific inhibitor Y-27632 [32] also improved reinnervation (Figure S6; Table S2).
To rule out non-specific effects of DN transgenes, we further investigated the function of ZF 
NgR, LINGO-1a, and CRMP-2 with morpholino antisense oligonucleotides (MO) targeting 
those genes. In all three cases, regenerating axons grew into denervated territory better than 
axons injected with a control MO (Figure 4; Figure S5G–J; Table S2). Expression of the full 
length LINGO-1a cDNA in neurons rescued the defect in repulsion observed in LINGO-1a 
morphants (Figure 4; Figure S5E,I,L, Table S2). These results support the idea that the NgR/
RhoA pathway functions in neurons to respond to inhibitors of axon regeneration in the skin.
To determine when this pathway is required to inhibit outgrowth of trigeminal axons in the 
skin, we injected Y-27632 into embryos 2 hours before axotomy, as well as 1, 4, or 12 hours 
after axotomy (Figure S6; Table S2). Reinnervation was only improved when ROCK was 
inhibited ≤4 hrs after axotomy. To determine whether the same pathway was responsible for 
diminishing the ability of intact neighboring axons to sprout at 78 hpf, Y-27632 was injected 
2 hours before ablation of an entire trigeminal ganglion. ROCK inhibition had no effect on 
the ability of uninjured axons from the intact ganglion to sprout across the midline (Table 
S3). Similarly, intact axons in LINGO-1a morphants did not grow into denervated territory 
after ablating a ganglion (Table S3). These results indicate that distinct pathways regulate 
the ability of injured and intact axon arbors to grow into denervated territory.
Discussion
It is generally believed that, in contrast to the CNS, the periphery is permissive for axon 
regeneration. Although substantial functional recovery from PNS injury can occur in 
adulthood, it is often incomplete [reviewed in 2]. Two phenomena are known to contribute to 
suboptimal PNS axon regeneration: the degeneration of supportive conduits that guide axons 
to the periphery and the inability of regenerating sensory endings to penetrate the epidermis 
[1–6]. We show here that inhibitory regions of skin can also be an obstacle to peripheral 
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reinnervation. After a developmental critical period, regenerating cutaneous sensory axon 
endings specifically avoid reinnervating their former territories. There is a crucial distinction 
between regeneration and reinnervation: severing an axon stimulates its growth, but factors 
in the original territory prevent reinnervation. Interestingly, severing axons in the CNS also 
stimulates exploratory activity, but very little reinnervation occurs [33], perhaps because 
axons are repelled by inhibitors expressed by myelin. When a regenerating trigeminal 
peripheral axon does grow into its former territory, it inevitably retracts or the cell dies, 
suggesting that repellents in this skin region may also be toxic to neurons. These local 
impediments to full reinnervation of the skin may contribute to deficits in functional 
recovery from peripheral injury [2].
Since inhibition is limited to a region around a degenerated axon’s original territory, we 
speculate that axons alter the extracellular matrix (ECM), leaving behind a persistent 
“ghost” that demarcates their former territories. This local mark of an axon’s territory might 
be laid down at a specific developmental stage to stabilize arbors. One possibility is that 
inhibitory factors derive from membrane-associated proteins mediating isoneuronal axon 
repulsion, perhaps after their ectodomains are shed from the membrane. Alternatively, axons 
may secrete distinct molecules into the ECM, or induce the surrounding epidermal cells to 
secrete inhibitors.
Perturbing Nogo receptor (NgR) signaling improved the ability of injured peripheral axons 
to reinnervate former territories. Several members of the Nogo Receptor (NgR) pathway, 
including NgR itself, its co-receptor LINGO-1, and the intracellular signaling molecules 
RhoA, Rho kinase and CRMP-2, are at least partially required in axons for avoidance of 
former territories in the skin. In the CNS this pathway is involved in responses to myelin-
associated proteins that inhibit axon regeneration [21]. Thus, the central and peripheral 
branches of somatosensory neurons use similar mechanisms to respond to inhibitors in 
distinct environments. It is possible that known ligands of the NgR complex, expressed in a 
different context, inhibit peripheral regeneration, but because these proteins are structurally 
diverse, it is also possible that different ligands functions in the periphery.
Our studies reveal a critical period for the plasticity of somatosensory arbors that limits their 
ability to respond to injury and fully reinnervate the skin. We propose that after initial 
development local inhibitors stabilize sensory arbors in the skin, consequently limiting their 
ability to reinnervate it after injury. Several molecular studies link functional recovery and 
axon regeneration following spinal cord injury to developmental plasticity in the CNS [34–
38]. The NgR pathway limits ocular dominance plasticity in the visual cortex [34], in 
addition to limiting regeneration in response to CNS injury [39, 40], and as we have now 
shown, PNS injury. Our results support the idea that impediments to recovery from injury to 
the mature PNS are a consequence of the stabilization of neuronal structure that occurs when 
initial morphogenesis ends.
Experimental Procedures
A previously described GFP reporter transgene was used to visualize trigeminal neurons 
(Tg(sensory:GFP)) [7], as well as a variation expressing RFP (Tg(sensory:RFP)) and an 
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Islet3-GFP line provided by Andrew Pittman and Chi-Bin Chien (Tg(Isl3:GFP))[41]. Details 
of time-lapse confocal imaging and 2-photon axotomy [8], data analysis, transplantation, 
pharmacological treatments, and morpholino and transgene design are described in 
supplemental data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Laser axotomy and imaging of peripheral axon regeneration
(A) Experimental design. Dorsal view of zebrafish embryo head; eyes are grey, trigeminal 
axons are green. Arrowhead indicates site of axotomy in all panels. Axon regeneration was 
monitored by time lapse for ≥ 12 hours and reinnervation of the denervated territory (yellow 
shading) by new axon growth (red) was calculated. (B) Dorsal and lateral views of a 
trigeminal axon reconstructed in 3-D. The axon arborizes within a mostly 2-D plane. (C–G) 
Time series of confocal image stacks. Same axon as in 1B. Time stamps are in minutes 
relative to axotomy at 30 hpf. Olive shading highlights the denervated region. Scale bar = 50 
μm. See Movie S1.
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Figure 2. The capacity for reinnervation diminishes during development
Axotomy at 30hpf (A–C), 54 hpf (D–F), or 78 hpf (G–I). Left two columns are confocal 
projections. Scale bars = 50 μm. Yellow arrowheads indicate site of axotomy, and olive 
overlay marks the territory that was denervated after axotomy. Blue dashed boxes indicate 
the area represented in rightmost panels (C, F, I), which show 3-D reconstructions of the 
same axon before axotomy (green) and 12 hours after axotomy (red), aligned at the shared 
branchpoint most proximal to the axotomy site. (J) Quantification of the average area 
reinnervated by injured axons, calculated as surface area of regenerated axon in denervated 
territory/surface area of denervated territory. (K) Quantification of average new axon growth 
that entered the denervated territory, calculated as length of new growth in denervated 
region/total length of new growth. Error bars ± S.E.M. See Table S1 and Movies S2–S4.
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Figure 3. Developmental regulation of territory reinnervation strategy
(A–C) Growth potential of uninjured axons is developmentally regulated. (A and B) 
Confocal projections. Dorsal view of zebrafish head, anterior up. Olive indicates denervated 
half of head. Scale bars = 50 μm. Ablation of the left trigeminal ganglion at 30 hpf (A) or 78 
hpf (B). (C) Quantification of axon growth rate in unablated (olive) vs. ablated (red) 
animals. Values are the average growth in μm per hour of individual branch tips. Error bars ± 
S.E.M. See Table S3 and Movies S5–S6. (D–G) Examples of control axons (wildtype cells 
transplanted into wildtype host) axotomized at 30 hpf (D) or 78 hpf (F), compared to 
isolated regenerating axons (wildtype cells transplanted into ngn-1 morphant host) 
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axotomized at 30 hpf (E) or 78 hpf (G). Tracing overlays as in Figure 2. Arrowhead is site of 
axotomy, olive marks denervated territory, and scale bars = 50 μm. (H) Quantification of the 
area reinnervated by the injured axon, calculated as in Figure 2J. Error bars ± S.E.M. See 
Table S1 and Movies S7–S10. (I) Model of the developmental regulation of skin 
reinnervation by the terminal arbors of peripheral sensory axons. Black bar indicates site of 
axotomy. Injured axons are red, uninjured axons are green.
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Figure 4. Inhibition of skin reinnervation by injured axons is mediated by the NgR/RhoA 
pathway
(A–C) Tracing overlays as in Figure 2. Arrowhead is site of axotomy, olive marks 
denervated territory, and scale bars = 50 μm. 78 hpf axotomy of a trigeminal neuron 
expressing GFP and RFP (A), DN NgR (B), or DN RhoA (C). (D) Quantification of fraction 
of axons that entered the denervated territory. Data to the left of the double bar were from 
axons expressing GFP and dominant negative or full length versions of the genes indicated. 
Data to the right of the double bar were from Tg(sensory:GFP) embryos injected with 
indicated morpholinos. Red indicates fraction of axons that grew into denervated territory, 
blue indicates axons that avoided denervated territory (See supplemental methods). See 
Table S2 and Movies S11–S13.
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